References

  1. Commonwealth of Australia. National Strategy for the Quality Use of Medicines Plain English edition. Canberra: Commonwealth of Australia, 2002. (accessed 5 February 2018).
  2. Pharmaceutical Benefits Scheme. Expenditure and prescriptions twelve months to 30 June 2017. Canberra: Department of Human Services, 2017. (accessed 20 February 2018).
  3. Gastrointestinal Expert Group. Therapeutic guidelines: Disorders of the oesophagus. West Melbourne: Therapeutic Guidelines Ltd, 2016. (accessed 23 January 2018).
  4. Australian Medicines Handbook. Gastro-oesophageal reflux disease. Adelaide: AMH Pty Ltd, 2018. (accessed 16 February 2018).
  5. World Gastroenterology Organisation. Global perspective on gastroesophageal reflux disease. Milwaukee, USA: WGO, 2015. (accessed 12 March 2018).
  6. Family Medicine Research Centre. SAND abstract No. 241 from the BEACH program: Proton pump inhibitor use among general practice patients. Sydney: University of Sydney, 2016. (accessed 12 March 2018).
  7. Haastrup P, Paulsen MS, Begtrup LM, et al. Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract 2014;31:625-30. 
  8. Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline. Can Fam Physician 2017;63:354-64. 
  9. Primary Health Tasmania. A guide to deprescribing proton pump inhibitors. Tasmania: Primary Health Tasmania, 2016. (accessed 14 June 2017).
  10. Kang JH-E, Kang JY. Lifestyle measures in the management of gastro-oesophageal reflux disease: clinical and pathophysiological considerations. Ther Adv Chronic Dis 2015;6:51-64. 
  11. National Institute of Clinical Excellence. Dyspepsia and gastro-oesophageal reflux disease. London: NICE, 2014. (accessed 12 March 2018).
  12. Australian Medicines Handbook. Proton pump inhibitors. Adelaide: AMH Pty Ltd, 2017. (accessed 15 October 2017).
  13. Prescribing PPIs. Drug Ther Bull 2017;55:117-20. 
  14. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf 2017;8:273-97.